Pharma Sector in Moldova

0% on retained earnings
for any company active in the Republic of Moldova, including pharmaceutical sector. 
7% unique tax
for R&D services, as part of MITP e-park
8% VAT tax
on retained earnings for any company active in the Republic of Moldova, including pharmaceutical sector. 
6,040 students pool of talent
The State University of Medicine and Pharmaceutics is leading by quality of studies and number of foreign students. 
1 of 6 strategic industries
2024-2028 National Industrialisation plan: 50% cash-back for eligible pharma investments, exceeding 500.000 EUR.

Moldovan
Pharma Market

The turnover of the pharma market has a constant grow in the last years.

Top origin country of the drugs sold in Moldova are: Germany, Slovenia, Switzerland, Hungary, and then Moldova. The production of Moldovan origin drugs has more than doubled in the last 5 years. There is still large potential for investment. 

$320 M

Turnover in 2023

+14,5%

Growth in 2023 vs. 2022

$620

Average Neto salary

Industry overview
Pharma Sector

4090 trade names in the state nomenclature of medicines (2023)
Locally produced only 9,6%. Opportunity to cover the other 90,4% of imported products
320,5 mln Pharmaceutical Market in the Republic of Moldova (2023)
Potential for growing to 400mln USD (by 2028)
30+ mln of packaging/year produced for export
Available capacity to increase volumes with 20+ mln/year
55% of the pharmaceutical products are exported = 11.25% of 2016-2020 country exports
Increase of 225% compared to the previous 5-year period

What do we produce?
And what do we export?

44,7 mil USD export volume in 2023

About 55% of drugs produced in Moldova are exported. 
Moldova exports over 30 mln packaging units for drugs, per year. 

Main export markets: CIS countries, including Georgia, Ukraine, Armenia, Azerbaidjan, Uzbekistan, Tajikistan, Russia. After COVID, more exports have been directed to the European Union countries (Poland, Baltic countries), but also Vietnam, Indonesia, Philippines, Pakistan, Libya, Kuwait, Yemen and Iraq.
Semi-solids
Suppositories
Ovules
Creams
Ointments
Pessaries
Liquid
Liquid Products (solutions for internal and external use)
Sprays
Emulsions
Suspensions
Syrups
Oils
Solid forms
Tablets
Capsules
Single-dose/multi-dose powders for solutions/suspensions
Sachets
Injectables
Solutions
Suspensions
Lyophilized
Pre-filled Syringes

Ecosystem players

Branch Associations
  • Association of Medicine Manufacturers from Moldova (APMM)
  • Employers' Association of Medical Devices and Laboratory Equipment Contractors (DISMED)
Policies and Regulators
  • Ministry of Health
  • Agency for Medicines and Medical Devices
Institutions of Higher Education
  • State University of Medicine and Pharmacy (USMF)
  • Moldova State University (USM)
  • Technical University Of Moldova (UTM)
Hospitals
  • National
  • Municipal
  • Private clinics
Consumers
Distribution
  • Importers/local distributors
  • Pharmacies

International students at State University of Medicine and Pharmacy

The collaboration between Nicolae Testemițanu State University of Medicine and Pharmacy and India has grown significantly since its inception, evolving into a robust partnership with 1,267 Indian students currently enrolled, primarily from Kerala and Tamil Nadu. 
India leads the international student community at USMF, with 1,267 Indian students representing over half of the total 2,267 foreign students, making it the largest national group studying at the institution.

Priority
Sector Pharma

Government Priority
The pharmaceutical industry is designated as a priority sector for Moldova's economic development by 2030. On June 5, 2024, the government adopted a decision in this regard
Investment Potential
According to forecasts by the German Economic Team, the pharmaceutical industry in Eastern Europe, including Moldova, has the potential to grow by over 25% in the next five years if conducive conditions are created.
Export Focus
Moldova's total exports from 2016-2020, a 225% increase compared to the previous five-year period

Medical
Tourism

Moldova has significant potential for medical tourism with specialized treatment services at very competitive costs. With 300 private hospitals and clinics, including 200 dental clinics, the country attract patients from all over the world. High quality services with lower costs, up to 90% savings comparing to USA or EU countries.
Starting 2024, Moldova holds the presidency of the Global Healthcare Travel Council (GHTC) and, over the next two years, the Medical Tourism Association plans to develop important projects related to technological innovations and developing wellness tourism.

The three areas in which Moldova excels are:

Dental treatment
Plastic surgery
In vitro fertilization
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram